Correction to: Leukemia (2017) 31, 1611–1621; doi:10.1038/leu.2016.352; published online 3 January 2017
Following the publication of this article, it was noted that the HTML version contained the wrong AAP date. The correct AAP date is 28 November 2016.
Additional information
The online version of the original article can be found at 10.1038/leu.2016.352
Rights and permissions
About this article
Cite this article
Cheadle, E., Lipowska-Bhalla, G., Dovedi, S. et al. Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells. Leukemia 31, 2278 (2017). https://doi.org/10.1038/leu.2017.218
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.218
This article is cited by
-
CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis
Cancer Immunology, Immunotherapy (2020)
